Senti Biosciences Holdings, Inc.
SNTI
$0.30
-$0.02-5.32%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -12.75M | -4.22M | -14.47M | -18.13M | -14.73M |
| Total Depreciation and Amortization | 667.00K | 688.00K | 893.00K | 904.00K | 914.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 1.08M | -5.39M | 6.48M | 1.55M | 1.57M |
| Change in Net Operating Assets | -3.24M | 1.45M | 222.00K | 6.23M | -819.00K |
| Cash from Operations | -14.25M | -7.48M | -6.88M | -9.45M | -13.07M |
| Capital Expenditure | -- | -- | 0.00 | 0.00 | -196.00K |
| Sale of Property, Plant, and Equipment | 0.00 | 114.00K | 0.00 | 0.00 | 12.00K |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 0.00 | 114.00K | 0.00 | 0.00 | -184.00K |
| Total Debt Issued | 9.70M | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | 10.51M | 136.00K | 534.00K |
| Repurchase of Common Stock | 0.00 | -118.00K | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -25.00K | -- | 530.00K | -12.00K | 477.00K |
| Cash from Financing | 9.68M | -118.00K | 11.04M | 124.00K | 1.01M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -4.57M | -7.49M | 4.17M | -9.32M | -12.25M |